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ABSTRACT 
Acyclovir [9-(2-hydroxyethoxymethyl) guanine] is an acyclic nucleoside analogue of guanosine that is a potent and selective 
antiviral agent. It has a relatively short plasma half-life (3 hr). When orally administered, it is slowly and scarcely absorbed from the 
gastrointestinal tract. The objective of the present work was to formulate and evaluate microspheres of Acyclovir and produced 
sustained drug delivery. In these 14 batches of acyclovir microspheres was prepared with using natural polymer Kondagogu gum and 
other ingredients by solvent evaporation technique. The prepared microspheres were evaluated for different parameters i.e % Drug 
yield, % drug entrapment, shape, surface morphology, particles size, polydispersity index, zeta potential and in-vitro drug release for 
48 hrs in phosphate buffer 7.4. The best batch was performed stability studies for 6 months. The research concluded that Acyclovir 
microspheres could be an alternative for conventional dosage form and other phytochemical in herbs. 
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INTRODUCTION 
Microspheres are one of the multi particulate drug 
delivery systems and are prepared to obtain prolonged 
(or) controlled drug delivery, to improve bioavailability 
or stability and to target drug to specific sites. 
Microspheres can be defined as solid, approximately 
spherical particles ranging from 1 to 1000μm, 
containing dispersed drug in either solution (or) 
microcrystalline form 
1, 2
. These microspheres are 
suitable alternatives for conventional dosage forms
3
. 
Several methods, including Emulsion solvent 
evaporation technique
4
, phase-separation or 
coacervation method
5
, emulsification diffusion method 
and spray drying method
6
 are commonly used for the 
preparation of microspheres. The solvent evaporation 
method has gained much attention due to its ease of 
fabrication without compromising the activity of drug. 
This technique offers several advantages and is 
preferable to other preparation methods such as spray 
drying, sonication and homogenization because it 
requires only mild conditions such as ambient 
temperature and constant stirring. Thus, a stable 
emulsion can be formed
7
 and microspheres are formed 
by the evaporation of an organic solvent from dispersed 
oil droplets containing both polymer and drug
8
. 
Microspheres are sometimes referred to as 
microparticles. Microspheres can be manufactured from 
various natural and synthetic materials. Glass 
microspheres, polymer microspheres and ceramic 
microspheres are commercially available. Solid and 
hollow microspheres vary widely in density and 
therefore, are used for different applications. Hollow 
microspheres are typically used as additives to lower the 
density of a material. Solid microspheres have numerous 
applications depending on what material they are 
constructed of and what size they are. Glass 
microspheres are primarily used as filler for weight 
reduction, retro-reflector for highway safety, additive for 
cosmetics and adhesives, with limited applications in 
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medical technology. Ceramic microspheres are used 
primarily as grinding media. Microspheres vary widely 
in quality, sphericity, uniformity of particle and particle 
size distribution
9
. Gums are natural polymers, which 
mainly consists of carbohydrates sometimes with small 
amounts of proteins and minerals. Increasing demand of 
natural ingredients over synthetic ones immensely 
contribute to explore and develop new plant based 
materials. Gum kondagogu (Cochlospermum 
gossypium) is a tree exudate derived from the Bixaceae 
family, riginating from India. Natural gums are obtained 
as exudates from different tree species, which exhibit 
unique and diverse physicochemical properties and have 
a wide variety of applications
10
. Commercially 
important tree gums include gum arabic, gum karaya, 
and gum tragacanth
11
. Karaya polysaccharide (Sterculia 
urens) and gum kondagogu (C. gossypium) are used as 
food additives
12, 13
. The physicochemical properties and 
toxicological evaluation of gum kondagogu has been 
established earlier
14, 15
. Morphological and structural 
characterization and physicochemical aspects of gum 
kondagogu have been elucidated recently, suggesting 
that this gum belongs to the group of substituted 
rhamnogalacturonans
16
. Understanding of the 
rheological properties of gum is essential for their 
application and use as food thickeners, stabilizers, and 
emulsifiers. Acyclovir (ACV) is known by its IUPAC 
name as 2-Amino-1,9-dihydro-9-[(2-
hydroxyethoxy)methyl]-6H-purin-6-one
17
. Acyclovir is 
a synthetic purine nucleoside analogue with in vitro and 
in vivo inhibitory activity against HSV-1, HSV-2 and 
Varicella Zoster Virus (VZV). Acyclovir is highly 
selective due to its affinity for the enzyme thymidine 
kinase (TK) encoded by HSV and VZV. This viral 
enzyme converts acyclovir into acyclovir 
monophosphate, a nucleoside analogue. The mono 
phosphate is further converted into tri phosphate by a 
number of cellular enzymes. Under in vitro conditions, 
acyclovir tri phosphate stops replication of herpes virus 
DNA. This is accomplished in three ways: competitive 
inhibition of viral DNA polymerases, incorporation into 
and termination of the viral DNA chain and inactivation 
of the viral DNA polymerases. The greater antiviral 
activity of acyclovir against HSV compared to VZV is 
due to its enhanced phosporylation by the viral TK
18
. 
The main objective of this work was to investigate the 
possibility of obtaining a sustained release formulation 
of acyclovir microspheres by the solvent evaporation 
method using gum kondagogu and Investigation of the 
effect of drug to polymer ratio. 
MATERIAL AND METHOD 
Material 
Acyclovir was procured from Scan Research 
Laboratories, Bhopal (MP). Kondagogu Gum was 
purchased from Himedia, Mumbai. Dialysis membrane 
(MWCO, 15 KDa), Span 80, Tween 80, 
Gulutaraldehyde, Toluene were purchased from 
Himedia (Mumbai, India). All other reagents and 
chemicals used were of analytical grade. 
Method 
Preparation of kondagogu gum microsphere 
The microspheres of the polysaccharide, Kondagogu 
Gum were prepared by emulsifying method using liquid 
paraffin as a dispersing medium and glutaraldehyde 
used as a cross-linking agent. Kondagogu gum 
dispersion (2.5 % w/v) was prepared by mixing of 
kondagogu gum in double distilled water with Tween 80 
(0.5% w/w). Drug was previously dissolved in double 
distilled water. The prepared, 10 ml of kondagogu gum 
solution with drug was added drop wise in a beaker 
containing 100 ml of liquid paraffin light and heavy in 
ratio of 50:50. Span 80 (1.0% w/v) was previously 
added in liquid paraffin.  The system was kept under 
stirring at 3000-4000 rpm using two blade mechanical 
stirrers. 1.5 ml of toluene saturated glutaraldehyde was 
added to above solution after 30 min of stirring. Stirring 
was continued for 4 hr at 40ᵒC at 4000 rpm.  The 
microspheres were separated from dispersion medium 
by centrifugation after stirring and washed two times 
with petroleum to remove liquid paraffin and then 
washed three times with acetone. Dispersion was poured 
in petridish to remove acetone. After complete 
evaporation of acetone, dried drug loaded microsphere 
were collected and stored in tight container for further 
evaluation.  
Optimization of microsphere 
Optimization of microsphere formulation was carried 
out by optimizing the different dependent and 
independent process and formulation variables.  
Optimization was carried out on the basis of particles 
size, polydispersity index and % drug entrapment and it 
is done by changing the one variable and kept constant 
for other variables given in table 1. The temperature was 
maintained at 40ᵒC and the concentration of toluene, 
saturated glutaraldehyde was used 1.5 ml in the 
preparation of each formulation. 
In Vitro Characterization of Microspheres  
Particle size, polydispersity index 
Average particles size, polydispersity index (PDI) of 
prepared microsphere was determined using zetasizer 
(DTS were.4.10, Horriba instrument, India). The 
microsphere formulation was diluted with deionized 
water (1:9 v/v) and analysed for average size and PDI 
and it was performed at the department of 
pharmaceutical science, VNS pharmacy college Bhopal, 
India Table 1.  
Shape and surface morphology 
The shape and surface morphology of the microspheres 
were investigated using scanning electron microscopy 
(IISER, Bhopal). The microspheres were fixed on 
supports with carbon-glue, and coated with gold using a 
gold sputter module in a high-vacuum evaporator. 
Samples were then observed with the Scanning Electron 
Microscope at 10 kV. 
 Determination of drug content 
The amount of drug entrapped in the microspheres was 
determined using a UV spectrophotometer. The weighed 
amount of the microspheres was incubated with PBS, 
pH 7.4, for 48 h. It was centrifuged at 10,000 g for 30 
min and the supernatant was diluted 10 times before 
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analysis into the UV spectrophotometer system at λmax 
252 nm.  
 In Vitro drug release from microspheres  
The drug release was performed in PBS (7.4 pH) for 
acyclovir loaded kondagogu gum microsphere. The drug 
release was performed in PBS (7.4 pH) for prepared 
microsphere using dialysis bag technique. In this study 
suspension of microsphere equivalent to 20 mg of drug 
was taken in dialysis tubing (MWCO, 15KDa, himedia) 
and placed in a beaker containing 50ml of PBS pH 7.4. 
The dialysis bag retains microsphere and allows passing 
of free drug into the dissolution media. Temperature was 
maintained at 37±1
0
C throughout the study. The samples 
were withdrawn after specified time intervals that is 0.5, 
1, 2, 3, 4, 5, 6, 7.8.12, 24 and 48 hrs and replaced with 
the same volume of fresh PBS pH 7.4 and analyzed for 
drug concentration by using UV spectrophotometer a 
λmax 252 nm Table 2. 
RESULT AND DISCUSSION 
The mean diameter of glutaraldehyde cross linked 
microspheres of kondagogu gum increased from 
56.70±2.15 µm to 88.15±4.25 µm with increasing 
polymer concentration from 1.0 to 3.0 % w/v. In the 
present investigation a 2.5% w/v kondagogu gum 
concentration was found to be optimized which give the 
required size of microspheres. The average particle size 
of microspheres increased with increasing polymer 
concentration, since at higher concentrations the 
polymer solution dispersed into larger droplets due to 
increasing the viscosity of polymer solution and it was 
the reason behind the enhancement of average particle 
size of microsphere. Mean particle size and size 
distribution were studied to observe the effect of drug 
concentration. It was found from previous study that 
there was no major change observed on particle size and 
size distribution of microsphere with varying 
concentration of the cross linking agent. Percent 
encapsulation efficiency has increased up to 
77.37±3.15% with increasing polymer drug 
concentration from 15% to 25 % w/w. But further 
increasing the concentration of drug, there was no 
significant enhancement was found in entrapment 
efficiency.  The in vitro dissolution profile of acyclovir 
in PBS pH 7.4 was found 83.46% after 48 hr for 
optimized formulation (KMTSD-13) and follow the 
matrix diffusion Higuchi release kinetics Fig 1-6. 
  
Table 1: Formulation of microsphere 
F. Code 
Kondagogu 
Gum (%w/v) 
Tween-80 
(%) 
Span-80 
(%) 
Stirring 
Speed 
Drug 
Conc. 
(% w/w) 
PDI 
Particle 
Size (µm) 
% Drug 
Entrapment 
KMS-1 1.5 1 0.5 2000  0.210±0.005 56.70±2.15 - 
KMS-2 2 1 0.5 2000  0.316±0.025 64.34±3.26 - 
KMS-3 2.5 1 0.5 2000  0.153±0.023 71.62±4.56 - 
KMS-4 3 1 0.5 2000 - 0.331±0.045 88.15±4.25 - 
KMT-5 2.5 1 0.5 2000 - 0.263±0.012 65.45±0.12 - 
KMT-6 2.5 1.5 0.5 2000 - 0.143±0.045 58.56±0.45 - 
KMT-7 2.5 2 0.5 2000 - 0.2 01±0.036 47.36±0.32 - 
KMTS-8 2.5 1.5 0.75 2000 - 0.150±0.012 38.62±3.26 - 
KMTS-9 2.5 1.5 1.0 2000 - 0.147±0.054 32.54±4.56 - 
KMTS-10 2.5 1.5 1.25 2000 - 0.164±0.005 28.27±2.66 - 
KMTS-11 2.5 1.5 1.0 2000 - 0.170±0.012 31.63±4.53 - 
KMTS-12 2.5 1.5 1.0 3000 - 0.135±0.023 22.54±3.12 - 
KMTS-13 2.5 1.5 1.0 4000 - 0.120±0.015 18.37±2.12 - 
KMTSD-11 2.5 1.5 1.0 4000 15 0.125±0.012 16.63±4.56 68.63±4.56 
KMTSD-12 2.5 1.5 1.0 4000 20 0.132±0.023 20.54±3.15 74.54±3.12 
KMTSD-13 2.5 1.5 1.0 4000 25 0.115±0.015 23.37±2.16 77.37±3.15 
KMTSD-14 2.5 1.5 1.0 4000 30 0.280±0.015 23.37±2.12 77.62±2.02 
 
Table 2: In vitro drug release 
S. No. Time interval 
(h) 
Plain drug Acyclovir Loaded 
Microsphere 
1 0.5 36.59 08.43 
2 1 49.15 16.53 
3 2 72.79 28.26 
4 3 91.38 35.68 
5 4 98.49 46.35 
6 5  54.23 
7 6  62.45 
8 8  69.38 
9 12  74.43 
10 24  79.34 
11 48  83.46 
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Figure 1: Effect of Kondagogu gum concentration on average particle size and PDI of microsphere 
 
 
Figure 2: Effect of concentration of Tween 80 on average particle size and PDI of microsphere 
 
 
Figure 3: Effect of Span 80 concentration on average particle size and PDI of microsphere 
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Figure 4: Effect of stirring speed concentration on average particle size and PDI of microsphere 
 
 
Figure 5: Effect of drug concentration on average particle size and % entrapment efficiency of microsphere 
 
 
Figure 6: Cumulative % acyclovir release 
CONCLUSION 
It was concluded that from this study that the 
microsphere can be prepared from kondagogu gum by 
emulsifying solvent evaporation method and can be 
loaded with drug acyclovir for it sustained delivery in 
GIT system. The prepared microspheres were optimized 
for different formulation and process variables 
concentration and found that microsphere was uniform 
and acceptable size range. They were found smooth and 
spherical in shape. The optimized formulation was 
found significant loading efficiency of acyclovir that can 
release the acyclovir in sustained manner which was 
followed matrix diffusion Higuchi release kinetic. 
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